Obstetrics & Gynecology · Public Health · 1 h ago
Patient agreement form did not meaningfully improve medication abortion knowledge
A randomized study of 593 patients at five US facilities found high knowledge of medication abortion after standard clinic counseling. Reviewing and signing the FDA-required patient agreement form was not associated with a clinically meaningful increase in knowledge.
- Study included 593 patients at five US facilities.
- Knowledge scores were high after standard clinic counseling.
- PAF exposure did not significantly increase knowledge.
- Misoprostol timing was correctly identified by 77%.
Researchers recruited patients aged 15 years or older receiving mifepristone and misoprostol at five facilities in California, Colorado, Illinois, Kansas, and Minnesota from January to October 2025. After standard clinic counseling and receipt of the medication guide, participants were randomized to complete a 12-item knowledge survey either before receiving the patient agreement form (PAF; 301 participants) or after receiving and signing it, including any related counseling (292 participants). The survey covered when to seek care, treatment effectiveness and administration, serious risks, and side effects.
Participants answered a mean of 10.37 of 12 items in a manner consistent with the PAF. Adjusted scores were 10.26 in the control group and 10.44 in the exposed group, an adjusted difference of 0.18 items (95% CI, −0.04 to 0.39). Most participants knew to contact a provider for infection (99%) or heavy bleeding (96%). Knowledge was lower for how often treatment does not work (54%) and when to take misoprostol (77%).
The study found no clinically meaningful knowledge gain after exposure to the PAF. The authors said the findings raise questions about the form’s usefulness under the FDA’s Risk Evaluation and Mitigation Strategy requirements. The results assess knowledge after counseling in patients at five facilities; they do not establish the effects of changing the regulatory requirement.
In practice
Among patients receiving mifepristone and misoprostol at five US facilities, knowledge after standard counseling was high, and the randomized comparison found no clinically meaningful increase after receipt and signing of the FDA-required patient agreement form. This suggests the form, as studied, may add little to knowledge beyond standard counseling. The study does not establish that counseling or the form should be changed, and its findings do not determine whether the regulatory requirement should be revised; results may not generalize beyond the participating facilities and languages.
AI-generated clinical interpretation · Not editor-reviewed
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
JAMA Internal Medicine: Mifepristone Patient Agreement Form and Medication Abortion Knowledge ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.